Deloitte March 30, 2021

Perspectives

How pharma and medtech can shift from doing digital to being digital

Digital transformation is no longer a buzzword—it’s a strategic imperative. Life Science companies should tackle enterprise-wide digital transformation head-on with a holistic, business-driven approach.

Digital transformation: A new competitive imperative

A convergence of events— COVID-19, the acceleration of digital health, economic uncertainty, ecosystem collaboration, and new competition—has impacted life sciences by both accelerating and advancing digital initiatives already underway, and it has jump-started future initiatives. Companies that understand the impact of these events also understand that to thrive, they should change the way they approach digital transformation.

In an...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Digital Health, Health IT, Pharma / Biotech, Technology
Gilead bets on Xilio cancer drug as biotech restructures
Pfizer shifts creative to Publicis in latest marketing move
Boundless Bio’s ‘BOLD’ IPO Reels In $100M for a New Kind of Cancer Drug
Joseph La Barge On The Challenges Of Advancing Gene Therapy, Finding The Right Support
Exact Sciences' posts positive data for its capsule-on-a-string test for esophageal cancer

Share This Article